Cargando…
Corrigendum to “In Vivo Resistance to Ceftolozane/Tazobactam in Pseudomonas aeruginosa Arising by AmpC- and Non-AmpC-Mediated Pathways”
Autores principales: | Skoglund, Erik, Abodakpi, Henrietta, Rios, Rafael, Diaz, Lorena, De La Cadena, Elsa, Dinh, An Q., Ardila, Javier, Miller, William R., Munita, Jose M., Arias, Cesar A., Tam, Vincent H., Tran, Truc T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745093/ https://www.ncbi.nlm.nih.gov/pubmed/31565449 http://dx.doi.org/10.1155/2019/8314349 |
Ejemplares similares
-
In Vivo Resistance to Ceftolozane/Tazobactam in Pseudomonas aeruginosa Arising by AmpC- and Non-AmpC-Mediated Pathways
por: Skoglund, Erik, et al.
Publicado: (2018) -
Ceftolozane-Tazobactam Resistance in Multidrug-Resistant Pseudomonas aeruginosa Isolates Not Associated with AmpC Activity
por: Tran, Truc T, et al.
Publicado: (2017) -
Characterization of Pseudomonas aeruginosa resistance to ceftolozane-tazobactam due to ampC and/or ampD mutations observed during treatment using semi-mechanistic PKPD modeling
por: Deroche, Luc, et al.
Publicado: (2023) -
Database for the ampC alleles in Acinetobacter baumannii
por: Karah, Nabil, et al.
Publicado: (2017) -
594. A Multi-Centered Study of the Clinical and Molecular Epidemiology of AmpC Cephalosporinase-Producing (AmpC) Enterobacteriaceae (Ent) Infections in Children
por: Medernach, Rachel L, et al.
Publicado: (2019)